OBJECTIVE: To analyze the microvascular network in skeletal muscle biopsies from patients with dermatomyositis (DM) and systemic sclerosis (SSc) compared to polymyositis (PM) and systemic lupus erythematosus (SLE), and non-inflammatory myopathies, and to clarify whether reparative angiogenesis-related factors are expressed in parallel to blood vessel damage. METHODS: Immunohistochemical staining of muscle biopsies (10 DM, 10 SSc, 10 PM, 10 SLE, and 10 non-inflammatory myopathies) with antibodies against von Willebrand factor (vWF), hypoxia-inducible factor-1beta (HIF-1beta), beta3 integrin subunit, and vascular endothelial growth factor receptor-1 (VEGFR-1). The TechMate staining robot and biotin-streptavidin protocol were used. RESULTS: DM and SSc muscles were characterized by endothelial damage and reduction of blood vessel network. Expression of angiogenesis-related factors (HIF-1beta, beta3, VEGFR-1) was also found in the same biopsies. In contrast, in PM and SLE muscles, vascular networks were apparently not affected and angiogenic stimuli were less expressed if at all. CONCLUSIONS: This work demonstrates that in inflamed muscles hypoxia/ischemia induces increased expression of angiogenic factors, yet their impact is insufficient to repair disease-associated reduction of the capillary network. This leads to questions considering the usefulness of angiogenic factors in the treatment of ischemic inflammatory myopathies in DM and SSc.
OBJECTIVE: To analyze the microvascular network in skeletal muscle biopsies from patients with dermatomyositis (DM) and systemic sclerosis (SSc) compared to polymyositis (PM) and systemic lupus erythematosus (SLE), and non-inflammatory myopathies, and to clarify whether reparative angiogenesis-related factors are expressed in parallel to blood vessel damage. METHODS: Immunohistochemical staining of muscle biopsies (10 DM, 10 SSc, 10 PM, 10 SLE, and 10 non-inflammatory myopathies) with antibodies against von Willebrand factor (vWF), hypoxia-inducible factor-1beta (HIF-1beta), beta3 integrin subunit, and vascular endothelial growth factor receptor-1 (VEGFR-1). The TechMate staining robot and biotin-streptavidin protocol were used. RESULTS:DM and SSc muscles were characterized by endothelial damage and reduction of blood vessel network. Expression of angiogenesis-related factors (HIF-1beta, beta3, VEGFR-1) was also found in the same biopsies. In contrast, in PM and SLE muscles, vascular networks were apparently not affected and angiogenic stimuli were less expressed if at all. CONCLUSIONS: This work demonstrates that in inflamed muscles hypoxia/ischemia induces increased expression of angiogenic factors, yet their impact is insufficient to repair disease-associated reduction of the capillary network. This leads to questions considering the usefulness of angiogenic factors in the treatment of ischemic inflammatory myopathies in DM and SSc.
Authors: W A Schmidt; W Wetzel; R Friedländer; R Lange; H F Sörensen; H J Lichey; E Genth; R Mierau; E Gromnica-Ihle Journal: Clin Rheumatol Date: 2000 Impact factor: 2.980
Authors: A Ceponis; Y T Konttinen; Z MacKevicius; S A Solovieva; M Hukkanen; M Tamulaitiene; A Matulis; S Santavirta Journal: J Rheumatol Date: 1996-11 Impact factor: 4.666
Authors: F Paulhe; C Racaud-Sultan; A Ragab; C Albiges-Rizo; H Chap; N Iberg; O Morand; B Perret Journal: J Biol Chem Date: 2001-09-10 Impact factor: 5.157
Authors: M C Cid; J M Grau; J Casademont; E Tobías; A Picazo; B Coll-Vinent; J Esparza; E Pedrol; A Urbano-Márquez Journal: Clin Exp Immunol Date: 1996-06 Impact factor: 4.330
Authors: Kanneboyina Nagaraju; Lisa G Rider; Chenguang Fan; Yi-Wen Chen; Megan Mitsak; Rashmi Rawat; Kathleen Patterson; Cecilia Grundtman; Frederick W Miller; Paul H Plotz; Eric Hoffman; Ingrid E Lundberg Journal: J Autoimmune Dis Date: 2006-02-20
Authors: Bridie J Goggins; Ciaran Chaney; Graham L Radford-Smith; Jay C Horvat; Simon Keely Journal: Front Immunol Date: 2013-09-11 Impact factor: 7.561